Literature DB >> 17337772

A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency.

Sherrie Divito1, Thomas L Cherpes, Robert L Hendricks.   

Abstract

Herpes simplex virus type 1 (HSV-1) travels by retrograde transport to sensory ganglia where latency is established. Recurrent disease results from virus reactivation and anterograde transport to nerve termini. Prevention of reactivation requires a complex interplay among virus, neuron, and immune response. Study of this tripartite relationship suggests possible interaction, and even communication among these components, that direct an immune response that allows for control of virus while preserving the viability of host tissue. Exciting new evidence supports the view that CD8+ effector T cells employ both lytic granule-dependent and interferon gamma-dependent effector mechanisms in maintaining HSV-1 latency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17337772     DOI: 10.1385/IR:36:1:119

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  42 in total

Review 1.  Development of the vertebrate neuromuscular junction.

Authors:  J R Sanes; J W Lichtman
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

2.  Physiological regulation of the immunological synapse by agrin.

Authors:  A A Khan; C Bose; L S Yam; M J Soloski; F Rupp
Journal:  Science       Date:  2001-05-10       Impact factor: 47.728

3.  The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus.

Authors:  R Leopardi; C Van Sant; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection.

Authors:  Alexandra Svensson; Joanna Kaim; Carina Mallard; Annika Olsson; Ernst Brodin; Tomas Hökfelt; Kristina Eriksson
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

5.  Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  Virology       Date:  1997-11-10       Impact factor: 3.616

6.  HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas.

Authors:  K R Jerome; Z Chen; R Lang; M R Torres; J Hofmeister; S Smith; R Fox; C J Froelich; L Corey
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

7.  Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection.

Authors:  C Shimeld; S Efstathiou; T Hill
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript.

Authors:  Gail Henderson; Weiping Peng; Ling Jin; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler; Clinton Jones
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

9.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

10.  Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.

Authors:  Magdalena Wojtasiak; Claerwen M Jones; Lucy C Sullivan; Adam C Winterhalter; Francis R Carbone; Andrew G Brooks
Journal:  Int Immunol       Date:  2004-08-09       Impact factor: 4.823

View more
  44 in total

Review 1.  Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.

Authors:  Amelia R Hofstetter; Lucy C Sullivan; Aron E Lukacher; Andrew G Brooks
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

2.  Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication.

Authors:  Anna Lang; James D Brien; Ilhem Messaoudi; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

3.  Cell-type-specific tyrosine phosphorylation of the herpes simplex virus tegument protein VP11/12 encoded by gene UL46.

Authors:  George Zahariadis; Melany J Wagner; Rosalyn C Doepker; Jessica M Maciejko; Carly M Crider; Keith R Jerome; James R Smiley
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

Review 4.  Chemokine-mediated immune responses in the female genital tract mucosa.

Authors:  Maud Deruaz; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

5.  HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed.

Authors:  Guoying Zhou; Te Du; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

6.  Age-Dependent Differences in Pseudorabies Virus Neuropathogenesis and Associated Cytokine Expression.

Authors:  Sara Verpoest; Brigitte Cay; Herman Favoreel; Nick De Regge
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 7.  Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.

Authors:  Carine Savarin; Cornelia C Bergmann
Journal:  Curr Opin Pharmacol       Date:  2008-06-16       Impact factor: 5.547

Review 8.  New concepts in herpes simplex virus vaccine development: notes from the battlefield.

Authors:  Gargi Dasgupta; Aziz A Chentoufi; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

9.  Local advantage: skin DCs prime; skin memory T cells protect.

Authors:  Akiko Iwasaki
Journal:  Nat Immunol       Date:  2009-05       Impact factor: 25.606

Review 10.  HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.

Authors:  Christopher M Coleman; Li Wu
Journal:  Retrovirology       Date:  2009-06-01       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.